TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
17,559
17,558
13,342
28,533
Selling General and Administrative
10,185
8,764
7,949
10,436
Total Operating Expenses
27,744
26,322
21,291
38,969
Operating Income or Loss
-27,744
-26,322
-21,291
-38,969
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-
233
168
127
Income Before Tax
-27,499
-26,089
-21,123
-38,842
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-27,499
-26,089
-21,123
-38,842
Net Income
-27,499
-26,089
-21,123
-38,842
Net Income available to common shareholders
-30,765
-29,355
-21,123
-38,842
Reported EPS
Basic
-
-268.10
-317.00
-1.54k
Diluted
-
-268.10
-317.00
-1.54k
Weighted average shares outstanding
Basic
-
109
67
25
Diluted
-
109
67
25
EBITDA
-
-26,268
-21,221
-38,763